The effects of interventional mitral valve repair with the MitraClip system on the results of pulmonary function testing

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022435

Enrollment

150

Registered

2020-08-13

Start date

2018-06-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I34.0

Interventions

Group 1: Uncontrolled one-armed observational study (Clinical registry)

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: All participants had to have the following characteristics (inclusion criteria): A) Men and women of any ethnicity aged at least 18 years; B) Indication for interventional mitral valve repair using the MitraClip device according to the current available evidence regarding this treatment; C) Ability to give an informed consent after oral and written information.

Exclusion criteria

Exclusion criteria: A) Simultaneous participation in other studies; B) Lack of informed consent to the evaluation of their personal and medical data.

Design outcomes

Primary

Measure	Time frame
The aim of the study is to show that treatment with the Mitraclip method can improve the diffusing capacity of the lung for carbon monoxide (DLCO) in 6 weeks of follow-up; In this study we conducted the DLCO measurement before the intervention and 6 weeks post-procedural using body plethysmography.	—

Secondary

Measure	Time frame
efficacy	—

Countries

Germany

Contacts

Public ContactLucie Kretzler

Berlin Institute of Health (BIH)

lucie.kretzler@charite.de+4930450643584

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 22, 2026